Travoprost Ophthalmic Solution, 0.004%
These highlights do not include all the information needed to use TRAVOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TRAVOPROST OPHTHALMIC SOLUTION. TRAVOPROST ophthalmic solution (ionic buffered solution) 0.004%, for topical ophthalmic useInitial U.S. Approval: 2001
00dc284f-fd96-423b-bb8f-b90ee13439bf
HUMAN PRESCRIPTION DRUG LABEL
Jun 16, 2022
Mylan Pharmaceuticals Inc.
DUNS: 059295980
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Travoprost Ophthalmic Solution, 0.004%
Product Details
FDA regulatory identification and product classification information